Should You Buy Sanofi SA (SNY) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/26
Sanofi SA (SNY) is not a strong buy at the moment for a beginner, long-term investor. The technical indicators show a bearish trend, and the options data suggests a bearish sentiment with a high Put-Call ratio. Analysts have recently downgraded the stock, citing strategic risks and lack of pipeline catalysts. While there are some positive developments in clinical trials, they are not sufficient to outweigh the negative sentiment and risks. Given the lack of strong buy signals and the investor's preference for long-term growth, it is better to hold off on buying at this time.
Technical Analysis
The technical indicators are bearish. The MACD is below 0 and negatively contracting, RSI is neutral at 51.813, and the moving averages are in a bearish alignment (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 47.243, with key resistance at 48.806 and support at 45.681.
